nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—SIGMAR1—amyotrophic lateral sclerosis	0.673	1	CbGaD
Trifluoperazine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.0848	1	CbGbCtD
Trifluoperazine—Asphyxia—Riluzole—amyotrophic lateral sclerosis	0.017	0.167	CcSEcCtD
Trifluoperazine—Tetany—Riluzole—amyotrophic lateral sclerosis	0.00653	0.0641	CcSEcCtD
Trifluoperazine—Trismus—Riluzole—amyotrophic lateral sclerosis	0.00638	0.0626	CcSEcCtD
Trifluoperazine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.00622	0.0797	CbGeAlD
Trifluoperazine—Thrombocytopenic purpura—Riluzole—amyotrophic lateral sclerosis	0.00454	0.0445	CcSEcCtD
Trifluoperazine—Priapism—Riluzole—amyotrophic lateral sclerosis	0.00441	0.0432	CcSEcCtD
Trifluoperazine—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0295	CcSEcCtD
Trifluoperazine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00283	0.0277	CcSEcCtD
Trifluoperazine—CALM1—cranial nerve—amyotrophic lateral sclerosis	0.00266	0.0341	CbGeAlD
Trifluoperazine—CALM2—pons—amyotrophic lateral sclerosis	0.00264	0.0338	CbGeAlD
Trifluoperazine—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00263	0.0258	CcSEcCtD
Trifluoperazine—CALM1—pons—amyotrophic lateral sclerosis	0.00263	0.0337	CbGeAlD
Trifluoperazine—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00253	0.0248	CcSEcCtD
Trifluoperazine—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00242	0.0238	CcSEcCtD
Trifluoperazine—S100A4—embryo—amyotrophic lateral sclerosis	0.00223	0.0286	CbGeAlD
Trifluoperazine—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00218	0.0214	CcSEcCtD
Trifluoperazine—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00213	0.0209	CcSEcCtD
Trifluoperazine—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.002	0.0196	CcSEcCtD
Trifluoperazine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00176	0.0173	CcSEcCtD
Trifluoperazine—CALM2—peripheral nervous system—amyotrophic lateral sclerosis	0.00176	0.0225	CbGeAlD
Trifluoperazine—CALM1—peripheral nervous system—amyotrophic lateral sclerosis	0.00175	0.0224	CbGeAlD
Trifluoperazine—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0169	CcSEcCtD
Trifluoperazine—CALY—medulla oblongata—amyotrophic lateral sclerosis	0.00165	0.0211	CbGeAlD
Trifluoperazine—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00165	0.0161	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00164	0.0161	CcSEcCtD
Trifluoperazine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00162	0.0208	CbGeAlD
Trifluoperazine—HTR2A—pons—amyotrophic lateral sclerosis	0.0016	0.0205	CbGeAlD
Trifluoperazine—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0016	0.0157	CcSEcCtD
Trifluoperazine—CALY—spinal cord—amyotrophic lateral sclerosis	0.00147	0.0189	CbGeAlD
Trifluoperazine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0144	CcSEcCtD
Trifluoperazine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0144	CcSEcCtD
Trifluoperazine—S100A4—medulla oblongata—amyotrophic lateral sclerosis	0.00142	0.0183	CbGeAlD
Trifluoperazine—CALM2—nerve—amyotrophic lateral sclerosis	0.00137	0.0176	CbGeAlD
Trifluoperazine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00137	0.0175	CbGeAlD
Trifluoperazine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00136	0.0134	CcSEcCtD
Trifluoperazine—CALM1—nerve—amyotrophic lateral sclerosis	0.00136	0.0175	CbGeAlD
Trifluoperazine—EBPL—nervous system—amyotrophic lateral sclerosis	0.00136	0.0174	CbGeAlD
Trifluoperazine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00134	0.0131	CcSEcCtD
Trifluoperazine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00134	0.0131	CcSEcCtD
Trifluoperazine—EBPL—central nervous system—amyotrophic lateral sclerosis	0.0013	0.0167	CbGeAlD
Trifluoperazine—EBPL—cerebellum—amyotrophic lateral sclerosis	0.00128	0.0163	CbGeAlD
Trifluoperazine—S100A4—spinal cord—amyotrophic lateral sclerosis	0.00127	0.0163	CbGeAlD
Trifluoperazine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0124	CcSEcCtD
Trifluoperazine—DRD2—nerve—amyotrophic lateral sclerosis	0.00126	0.0161	CbGeAlD
Trifluoperazine—CALY—nervous system—amyotrophic lateral sclerosis	0.00124	0.0159	CbGeAlD
Trifluoperazine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0121	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00122	0.012	CcSEcCtD
Trifluoperazine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00122	0.0119	CcSEcCtD
Trifluoperazine—CALY—central nervous system—amyotrophic lateral sclerosis	0.00119	0.0153	CbGeAlD
Trifluoperazine—HTR2A—appendage—amyotrophic lateral sclerosis	0.00117	0.015	CbGeAlD
Trifluoperazine—CALY—cerebellum—amyotrophic lateral sclerosis	0.00117	0.015	CbGeAlD
Trifluoperazine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0114	CcSEcCtD
Trifluoperazine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0109	CcSEcCtD
Trifluoperazine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00107	0.0137	CbGeAlD
Trifluoperazine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0103	CcSEcCtD
Trifluoperazine—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00104	0.0134	CbGeAlD
Trifluoperazine—EBPL—brain—amyotrophic lateral sclerosis	0.00104	0.0133	CbGeAlD
Trifluoperazine—CALM2—hindbrain—amyotrophic lateral sclerosis	0.00103	0.0131	CbGeAlD
Trifluoperazine—CALM1—hindbrain—amyotrophic lateral sclerosis	0.00102	0.0131	CbGeAlD
Trifluoperazine—S100A4—cerebellum—amyotrophic lateral sclerosis	0.00101	0.0129	CbGeAlD
Trifluoperazine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.000962	0.0123	CbGeAlD
Trifluoperazine—CALY—brain—amyotrophic lateral sclerosis	0.000947	0.0121	CbGeAlD
Trifluoperazine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.000943	0.0121	CbGeAlD
Trifluoperazine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000904	0.00887	CcSEcCtD
Trifluoperazine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000895	0.00878	CcSEcCtD
Trifluoperazine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000872	0.00855	CcSEcCtD
Trifluoperazine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000856	0.00839	CcSEcCtD
Trifluoperazine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000851	0.00834	CcSEcCtD
Trifluoperazine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000833	0.00817	CcSEcCtD
Trifluoperazine—HTR2A—nerve—amyotrophic lateral sclerosis	0.00083	0.0106	CbGeAlD
Trifluoperazine—S100A4—brain—amyotrophic lateral sclerosis	0.000818	0.0105	CbGeAlD
Trifluoperazine—Cough—Riluzole—amyotrophic lateral sclerosis	0.000812	0.00797	CcSEcCtD
Trifluoperazine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000807	0.00791	CcSEcCtD
Trifluoperazine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000775	0.0076	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00076	0.00745	CcSEcCtD
Trifluoperazine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000738	0.00724	CcSEcCtD
Trifluoperazine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000724	0.0071	CcSEcCtD
Trifluoperazine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.000711	0.00911	CbGeAlD
Trifluoperazine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00071	0.00696	CcSEcCtD
Trifluoperazine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000687	0.00674	CcSEcCtD
Trifluoperazine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000677	0.00664	CcSEcCtD
Trifluoperazine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000675	0.00662	CcSEcCtD
Trifluoperazine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000661	0.00648	CcSEcCtD
Trifluoperazine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000655	0.00642	CcSEcCtD
Trifluoperazine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00065	0.00637	CcSEcCtD
Trifluoperazine—HTR6—nervous system—amyotrophic lateral sclerosis	0.000644	0.00826	CbGeAlD
Trifluoperazine—CALM2—embryo—amyotrophic lateral sclerosis	0.000641	0.00822	CbGeAlD
Trifluoperazine—CALM1—embryo—amyotrophic lateral sclerosis	0.000639	0.00819	CbGeAlD
Trifluoperazine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.000622	0.00797	CbGeAlD
Trifluoperazine—HTR6—central nervous system—amyotrophic lateral sclerosis	0.00062	0.00795	CbGeAlD
Trifluoperazine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000604	0.00592	CcSEcCtD
Trifluoperazine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000601	0.00589	CcSEcCtD
Trifluoperazine—HTR1A—brainstem—amyotrophic lateral sclerosis	0.000598	0.00767	CbGeAlD
Trifluoperazine—CALM2—brainstem—amyotrophic lateral sclerosis	0.000588	0.00754	CbGeAlD
Trifluoperazine—CALM1—brainstem—amyotrophic lateral sclerosis	0.000585	0.0075	CbGeAlD
Trifluoperazine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00056	0.00549	CcSEcCtD
Trifluoperazine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.000551	0.00707	CbGeAlD
Trifluoperazine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000545	0.00535	CcSEcCtD
Trifluoperazine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00054	0.00693	CbGeAlD
Trifluoperazine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000538	0.00527	CcSEcCtD
Trifluoperazine—CALM3—medulla oblongata—amyotrophic lateral sclerosis	0.000522	0.00669	CbGeAlD
Trifluoperazine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000502	0.00493	CcSEcCtD
Trifluoperazine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.000496	0.00635	CbGeAlD
Trifluoperazine—HTR6—brain—amyotrophic lateral sclerosis	0.000492	0.00631	CbGeAlD
Trifluoperazine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000479	0.0047	CcSEcCtD
Trifluoperazine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000479	0.00469	CcSEcCtD
Trifluoperazine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000476	0.00467	CcSEcCtD
Trifluoperazine—SIGMAR1—medulla oblongata—amyotrophic lateral sclerosis	0.000467	0.00598	CbGeAlD
Trifluoperazine—CALM3—spinal cord—amyotrophic lateral sclerosis	0.000465	0.00597	CbGeAlD
Trifluoperazine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00443	CcSEcCtD
Trifluoperazine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.000442	0.00566	CbGeAlD
Trifluoperazine—SIGMAR1—spinal cord—amyotrophic lateral sclerosis	0.000416	0.00533	CbGeAlD
Trifluoperazine—CALM2—medulla oblongata—amyotrophic lateral sclerosis	0.00041	0.00526	CbGeAlD
Trifluoperazine—CALM1—medulla oblongata—amyotrophic lateral sclerosis	0.000408	0.00523	CbGeAlD
Trifluoperazine—HTR2A—embryo—amyotrophic lateral sclerosis	0.000389	0.00499	CbGeAlD
Trifluoperazine—CHRM2—nervous system—amyotrophic lateral sclerosis	0.000386	0.00495	CbGeAlD
Trifluoperazine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.000372	0.00477	CbGeAlD
Trifluoperazine—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.000372	0.00477	CbGeAlD
Trifluoperazine—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.000372	0.00477	CbGeAlD
Trifluoperazine—CALM3—cerebellum—amyotrophic lateral sclerosis	0.000369	0.00473	CbGeAlD
Trifluoperazine—CALM2—spinal cord—amyotrophic lateral sclerosis	0.000366	0.00469	CbGeAlD
Trifluoperazine—CALM1—spinal cord—amyotrophic lateral sclerosis	0.000364	0.00466	CbGeAlD
Trifluoperazine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.000358	0.0046	CbGeAlD
Trifluoperazine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.000356	0.00457	CbGeAlD
Trifluoperazine—SIGMAR1—cerebellum—amyotrophic lateral sclerosis	0.00033	0.00423	CbGeAlD
Trifluoperazine—HTR1A—nervous system—amyotrophic lateral sclerosis	0.000313	0.00402	CbGeAlD
Trifluoperazine—CALM2—nervous system—amyotrophic lateral sclerosis	0.000308	0.00395	CbGeAlD
Trifluoperazine—CALM1—nervous system—amyotrophic lateral sclerosis	0.000307	0.00393	CbGeAlD
Trifluoperazine—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.000302	0.00387	CbGeAlD
Trifluoperazine—CALM3—brain—amyotrophic lateral sclerosis	0.0003	0.00384	CbGeAlD
Trifluoperazine—CALM2—central nervous system—amyotrophic lateral sclerosis	0.000297	0.0038	CbGeAlD
Trifluoperazine—CHRM2—brain—amyotrophic lateral sclerosis	0.000295	0.00379	CbGeAlD
Trifluoperazine—CALM1—central nervous system—amyotrophic lateral sclerosis	0.000295	0.00378	CbGeAlD
Trifluoperazine—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.000295	0.00378	CbGeAlD
Trifluoperazine—CALM2—cerebellum—amyotrophic lateral sclerosis	0.00029	0.00372	CbGeAlD
Trifluoperazine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.000289	0.0037	CbGeAlD
Trifluoperazine—CALM1—cerebellum—amyotrophic lateral sclerosis	0.000288	0.0037	CbGeAlD
Trifluoperazine—HTR2C—brain—amyotrophic lateral sclerosis	0.000285	0.00365	CbGeAlD
Trifluoperazine—DRD2—nervous system—amyotrophic lateral sclerosis	0.000283	0.00363	CbGeAlD
Trifluoperazine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.000278	0.00357	CbGeAlD
Trifluoperazine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.000273	0.0035	CbGeAlD
Trifluoperazine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.000272	0.00349	CbGeAlD
Trifluoperazine—SIGMAR1—brain—amyotrophic lateral sclerosis	0.000268	0.00343	CbGeAlD
Trifluoperazine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.000266	0.00342	CbGeAlD
Trifluoperazine—ABCB1—embryo—amyotrophic lateral sclerosis	0.000255	0.00327	CbGeAlD
Trifluoperazine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000249	0.00319	CbGeAlD
Trifluoperazine—HTR1A—brain—amyotrophic lateral sclerosis	0.00024	0.00307	CbGeAlD
Trifluoperazine—CALM2—brain—amyotrophic lateral sclerosis	0.000235	0.00302	CbGeAlD
Trifluoperazine—CALM1—brain—amyotrophic lateral sclerosis	0.000234	0.003	CbGeAlD
Trifluoperazine—HRH1—nervous system—amyotrophic lateral sclerosis	0.000224	0.00287	CbGeAlD
Trifluoperazine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000222	0.00284	CbGeAlD
Trifluoperazine—ADRA1A—brain—amyotrophic lateral sclerosis	0.000221	0.00283	CbGeAlD
Trifluoperazine—DRD2—brain—amyotrophic lateral sclerosis	0.000216	0.00277	CbGeAlD
Trifluoperazine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000215	0.00276	CbGeAlD
Trifluoperazine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000187	0.00239	CbGeAlD
Trifluoperazine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.00018	0.00231	CbGeAlD
Trifluoperazine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000176	0.00225	CbGeAlD
Trifluoperazine—Antrafenine—PTGS2—amyotrophic lateral sclerosis	0.000175	0.609	CrCbGaD
Trifluoperazine—HRH1—brain—amyotrophic lateral sclerosis	0.000171	0.00219	CbGeAlD
Trifluoperazine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000163	0.00209	CbGeAlD
Trifluoperazine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000145	0.00186	CbGeAlD
Trifluoperazine—HTR2A—brain—amyotrophic lateral sclerosis	0.000143	0.00183	CbGeAlD
Trifluoperazine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000122	0.00157	CbGeAlD
Trifluoperazine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000118	0.00151	CbGeAlD
Trifluoperazine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000115	0.00148	CbGeAlD
Trifluoperazine—Clomipramine—GSTP1—amyotrophic lateral sclerosis	0.000112	0.391	CrCbGaD
Trifluoperazine—ABCB1—brain—amyotrophic lateral sclerosis	9.35e-05	0.0012	CbGeAlD
Trifluoperazine—CALM1—Disease—CST3—amyotrophic lateral sclerosis	1.43e-05	0.000232	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.43e-05	0.000232	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	1.43e-05	0.000232	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	1.43e-05	0.000232	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.43e-05	0.000231	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—C3—amyotrophic lateral sclerosis	1.42e-05	0.000231	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.42e-05	0.00023	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.42e-05	0.00023	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.42e-05	0.00023	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.4e-05	0.000227	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.4e-05	0.000227	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.4e-05	0.000227	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.39e-05	0.000226	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.39e-05	0.000225	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—C3—amyotrophic lateral sclerosis	1.38e-05	0.000223	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—C3—amyotrophic lateral sclerosis	1.38e-05	0.000223	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—C3—amyotrophic lateral sclerosis	1.37e-05	0.000222	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.36e-05	0.00022	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.35e-05	0.00022	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.35e-05	0.00022	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—C3—amyotrophic lateral sclerosis	1.32e-05	0.000214	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—C3—amyotrophic lateral sclerosis	1.32e-05	0.000214	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.31e-05	0.000213	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—SQSTM1—amyotrophic lateral sclerosis	1.31e-05	0.000212	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.27e-05	0.000205	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—SQSTM1—amyotrophic lateral sclerosis	1.26e-05	0.000205	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—SQSTM1—amyotrophic lateral sclerosis	1.26e-05	0.000205	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.26e-05	0.000204	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.26e-05	0.000204	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.24e-05	0.000201	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.24e-05	0.000201	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.24e-05	0.0002	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.23e-05	0.000199	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—ATF1—amyotrophic lateral sclerosis	1.22e-05	0.000199	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.22e-05	0.000198	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.22e-05	0.000197	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.22e-05	0.000197	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.22e-05	0.000197	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.21e-05	0.000196	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.2e-05	0.000195	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.2e-05	0.000195	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.2e-05	0.000195	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.2e-05	0.000195	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.19e-05	0.000193	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.19e-05	0.000193	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—ATF1—amyotrophic lateral sclerosis	1.18e-05	0.000192	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—ATF1—amyotrophic lateral sclerosis	1.18e-05	0.000192	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.18e-05	0.000192	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.18e-05	0.000191	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.18e-05	0.000191	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.18e-05	0.000191	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.18e-05	0.000191	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.18e-05	0.000191	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.18e-05	0.000191	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.17e-05	0.00019	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.17e-05	0.00019	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CASP9—amyotrophic lateral sclerosis	1.17e-05	0.000189	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.14e-05	0.000185	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CASP9—amyotrophic lateral sclerosis	1.13e-05	0.000183	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CASP9—amyotrophic lateral sclerosis	1.13e-05	0.000183	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.11e-05	0.000181	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.11e-05	0.00018	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.1e-05	0.000179	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.1e-05	0.000178	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.09e-05	0.000177	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.09e-05	0.000177	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.08e-05	0.000176	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CASP9—amyotrophic lateral sclerosis	1.08e-05	0.000175	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.07e-05	0.000174	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.07e-05	0.000174	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.05e-05	0.00017	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.05e-05	0.00017	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CASP9—amyotrophic lateral sclerosis	1.04e-05	0.000169	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CASP9—amyotrophic lateral sclerosis	1.04e-05	0.000169	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.03e-05	0.000168	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.03e-05	0.000167	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.02e-05	0.000165	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.01e-05	0.000165	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.01e-05	0.000164	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.99e-06	0.000162	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—ERBB4—amyotrophic lateral sclerosis	9.98e-06	0.000162	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.96e-06	0.000161	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.94e-06	0.000161	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.94e-06	0.000161	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	9.93e-06	0.000161	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.86e-06	0.00016	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.7e-06	0.000157	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—ERBB4—amyotrophic lateral sclerosis	9.66e-06	0.000157	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—ERBB4—amyotrophic lateral sclerosis	9.66e-06	0.000157	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.54e-06	0.000155	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.52e-06	0.000154	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.41e-06	0.000152	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CD40LG—amyotrophic lateral sclerosis	9.39e-06	0.000152	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.37e-06	0.000152	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.34e-06	0.000151	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.23e-06	0.00015	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—ERBB4—amyotrophic lateral sclerosis	9.22e-06	0.000149	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.09e-06	0.000147	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD40LG—amyotrophic lateral sclerosis	9.08e-06	0.000147	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CD40LG—amyotrophic lateral sclerosis	9.08e-06	0.000147	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.08e-06	0.000147	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.07e-06	0.000147	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9e-06	0.000146	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.96e-06	0.000145	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.92e-06	0.000145	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—ERBB4—amyotrophic lateral sclerosis	8.92e-06	0.000145	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—ERBB4—amyotrophic lateral sclerosis	8.92e-06	0.000145	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.9e-06	0.000144	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	8.89e-06	0.000144	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.78e-06	0.000142	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.78e-06	0.000142	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.46e-06	0.000137	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.44e-06	0.000137	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.42e-06	0.000136	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—C3—amyotrophic lateral sclerosis	8.3e-06	0.000134	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.17e-06	0.000132	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.17e-06	0.000132	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.11e-06	0.000132	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—C3—amyotrophic lateral sclerosis	8.03e-06	0.00013	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—C3—amyotrophic lateral sclerosis	8.03e-06	0.00013	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—VEGFA—amyotrophic lateral sclerosis	7.95e-06	0.000129	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.92e-06	0.000128	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.9e-06	0.000128	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.9e-06	0.000128	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.78e-06	0.000126	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.77e-06	0.000126	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.76e-06	0.000126	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	7.69e-06	0.000125	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	7.69e-06	0.000125	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.66e-06	0.000124	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.66e-06	0.000124	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.64e-06	0.000124	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.64e-06	0.000124	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.64e-06	0.000124	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.61e-06	0.000123	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.54e-06	0.000122	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.48e-06	0.000121	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.44e-06	0.000121	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.43e-06	0.00012	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.31e-06	0.000119	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.3e-06	0.000118	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.3e-06	0.000118	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.3e-06	0.000118	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.26e-06	0.000118	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.18e-06	0.000116	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.16e-06	0.000116	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—APOE—amyotrophic lateral sclerosis	7.13e-06	0.000116	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.02e-06	0.000114	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.02e-06	0.000114	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.96e-06	0.000113	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.93e-06	0.000112	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—APOE—amyotrophic lateral sclerosis	6.9e-06	0.000112	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—APOE—amyotrophic lateral sclerosis	6.9e-06	0.000112	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.57e-06	0.000106	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.46e-06	0.000105	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.46e-06	0.000105	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.45e-06	0.000105	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.34e-06	0.000103	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.33e-06	0.000103	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.24e-06	0.000101	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.24e-06	0.000101	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.11e-06	9.91e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.07e-06	9.84e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.02e-06	9.75e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—TP53—amyotrophic lateral sclerosis	6.01e-06	9.74e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6e-06	9.73e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.99e-06	9.7e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.98e-06	9.7e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—APOE—amyotrophic lateral sclerosis	5.97e-06	9.68e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.91e-06	9.58e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.89e-06	9.55e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.87e-06	9.52e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.87e-06	9.52e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—TP53—amyotrophic lateral sclerosis	5.81e-06	9.42e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—TP53—amyotrophic lateral sclerosis	5.81e-06	9.42e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—APOE—amyotrophic lateral sclerosis	5.78e-06	9.37e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—APOE—amyotrophic lateral sclerosis	5.78e-06	9.37e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.75e-06	9.33e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.72e-06	9.28e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.65e-06	9.17e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.56e-06	9.01e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.5e-06	8.92e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.36e-06	8.7e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.19e-06	8.41e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.19e-06	8.41e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.08e-06	8.23e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.05e-06	8.19e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.99e-06	8.1e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.97e-06	8.06e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.96e-06	8.04e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PTGS2—amyotrophic lateral sclerosis	4.89e-06	7.92e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.88e-06	7.91e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.87e-06	7.89e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.83e-06	7.83e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.83e-06	7.83e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.78e-06	7.75e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PTGS2—amyotrophic lateral sclerosis	4.73e-06	7.66e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PTGS2—amyotrophic lateral sclerosis	4.73e-06	7.66e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	4.53e-06	7.34e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.43e-06	7.18e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.41e-06	7.14e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.39e-06	7.12e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.19e-06	6.79e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.16e-06	6.75e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.13e-06	6.69e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.09e-06	6.63e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.99e-06	6.47e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.99e-06	6.47e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.96e-06	6.42e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.96e-06	6.42e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.89e-06	6.3e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.84e-06	6.22e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.83e-06	6.2e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.82e-06	6.19e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.76e-06	6.09e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.76e-06	6.09e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.75e-06	6.07e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.74e-06	6.06e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.67e-06	5.96e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.62e-06	5.86e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.61e-06	5.86e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.61e-06	5.85e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.55e-06	5.76e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.54e-06	5.74e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.3e-06	5.35e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.25e-06	5.26e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.24e-06	5.25e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.19e-06	5.17e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.18e-06	5.15e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.18e-06	5.15e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.1e-06	5.03e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.07e-06	4.98e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.07e-06	4.98e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3e-06	4.87e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.9e-06	4.71e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.9e-06	4.71e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.84e-06	4.6e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.83e-06	4.58e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.7e-06	4.37e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.61e-06	4.23e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.61e-06	4.23e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.49e-06	4.04e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.48e-06	4.01e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.45e-06	3.98e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.45e-06	3.97e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.41e-06	3.9e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.4e-06	3.89e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.04e-06	3.3e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.97e-06	3.19e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.97e-06	3.19e-05	CbGpPWpGaD
